The impact of EV extraction methods was reduced in PSA-miRNA combined models that conserve the statistical power as molecular classifier to distinguish benign from malignant tumours with any of the three EV isolation techniques and thus, have the potential to reduce unnecessary biopsies in the PSA “grey zone” (PSA between 4–10 ng/mL). The gene discussed is KLK3; the disease is cancer.